Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
Stocks in this Quantisnow insightHealth Care
Historical context for RPRX
Across the 20 sessions after earlier RPRX headlines, the stock closed higher 15 times and lower 5 times, with a median move of 0.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | RPRX | SPY |
|---|---|---|---|
| May 8, 2026 | Royalty Pharma to present at upcoming investor conferences | +1.2% | +0.8% |
| May 6, 2026 | Royalty Pharma reports first quarter 2026 results | +0.6% | +1.4% |
| Apr 21, 2026 | Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation | +0.4% | -0.7% |
| Apr 17, 2026 | Royalty Pharma Declares Second Quarter 2026 Dividend | +3.1% | +1.2% |
| Apr 16, 2026 | Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 | -0.5% | +0.2% |
| Mar 30, 2026 | Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases | +0.0% | -0.3% |
Quantisnow market dataNASDAQ
RPRX
Royalty Pharma plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for RPRX
Full RPRX profile on Quantisnow Follow RPRX and get a push notification the moment its next story breaks.